Medicines co /de (MDCO)
Income statement / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Net revenues

0

0

0

0

-3,300

1,667

7,771

8,595

7,868

10,861

17,465

525

37,599

54,731

50,306

52,707

57,206

74,519

110,115

126,280

172,401

183,774

177,235

121,747

174,282

172,826

155,753

159,490

136,786

135,702

126,610

132,231

120,773

119,591

112,137

119,679

105,743

110,135

102,088

98,789

104,175

Net product revenues

-

-

-

-

-

-

-

-

-

-

-

-

18,843

30,324

31,375

23,351

32,703

74,519

110,115

-

172,401

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty revenues

-

-

-

-

-

-

-

-

-

-

-

-

18,756

24,407

18,931

29,356

24,503

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Cost of revenues

0

0

0

697

890

2,931

2,737

20,438

4,287

12,490

9,978

5,849

20,777

15,230

18,797

9,504

49,188

24,756

20,538

11,700

69,076

85,687

66,867

30,190

65,794

63,938

56,714

52,228

43,767

42,681

38,663

44,007

39,459

37,830

35,570

35,394

31,568

33,568

28,769

28,308

30,353

Asset impairment charges

0

-

-

-

5,073

-

-

-

0

329,097

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

42,770

28,112

27,011

29,611

32,736

30,294

40,366

55,600

33,077

23,249

26,444

-2,488

23,537

37,567

33,491

6,968

27,102

33,035

23,283

33,874

33,314

41,228

31,096

29,852

23,187

27,025

58,196

26,147

34,536

32,962

32,778

33,302

26,550

26,536

23,792

31,113

16,676

20,575

16,877

22,464

21,784

Selling, general and administrative

18,599

19,889

16,982

-4,576

6,826

21,013

28,951

29,644

33,765

28,359

40,457

-29,996

69,022

94,158

79,298

24,314

86,892

93,309

80,785

79,026

82,662

88,745

64,521

68,869

62,528

52,944

63,482

44,704

43,396

40,467

43,186

34,916

45,353

41,420

37,928

37,372

35,788

39,409

46,121

47,358

45,910

Total operating expenses

61,369

48,001

43,993

25,732

45,525

54,238

72,054

168,682

71,129

393,195

76,879

-26,635

113,336

146,955

131,586

40,786

163,182

151,100

124,606

124,600

185,052

215,660

162,484

128,911

151,509

143,907

178,392

123,079

121,699

116,110

114,627

112,225

111,362

105,786

97,290

103,879

84,032

93,552

91,767

98,130

98,047

Loss from operations

-61,369

-48,001

-43,993

-25,732

-48,825

-52,571

-64,283

-160,087

-63,261

-382,334

-59,414

27,160

-75,737

-92,224

-81,280

11,921

-105,976

-76,581

-14,491

1,680

-12,651

-31,886

14,751

-7,164

22,773

28,919

-22,639

36,411

15,087

19,592

11,983

20,006

9,411

13,805

14,847

15,800

21,711

16,583

10,321

659

6,128

Legal settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

0

0

17,984

0

0

0

0

-

-

Co-promotion and license income

4,402

0

0

266

271

254

228

5,266

769

757

757

781

757

1,341

975

121

985

638

8,388

8,026

2,864

7,326

6,020

5,142

4,423

4,068

3,750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on short-term investment

-1,900

2,100

-300

-10,381

-8,000

-3,500

-30,000

0

0

0

0

-

-

-

-

-

0

19,773

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on remeasurement of equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-144

0

0

22,741

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of business

-

-

-

-

-

-

-

-

-

-

-

-

0

288,301

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Co-promotion and profit share income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,750

3,750

2,500

0

-

0

0

-

-

-

-

-

-

-

Loss in equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-144

-527

-1,184

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

0

-5,380

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

16,212

15,791

16,024

12,913

12,313

12,108

12,077

11,811

11,810

12,521

12,422

12,265

12,089

10,363

9,746

9,582

9,547

9,348

8,615

3,991

3,958

3,892

3,860

4,388

3,765

3,704

3,674

3,616

3,605

784

0

-

0

0

-

-

-

-

-

-

-

Investment impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,500

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

1,088

1,687

421

1,039

1,119

1,053

2,369

248

448

1,033

111

-395

865

138

-262

-421

-89

231

467

942

-53

-150

179

234

383

605

198

177

204

697

62

340

578

61

811

-322

483

-117

-311

151

734

Loss from continuing operations before income taxes

-73,984

-60,048

-59,862

-47,805

-67,701

-66,846

-103,752

-166,384

-73,854

-393,065

-70,968

15,281

-86,204

181,813

-90,313

2,039

-109,627

-65,287

8,346

31,866

-22,482

-28,602

17,090

-6,176

23,814

29,888

-22,365

36,722

15,436

22,005

12,045

20,346

9,989

13,866

33,642

15,478

22,194

16,466

10,010

810

6,862

(Provision for) benefit from income taxes

10

10

3

-3,488

-16,100

-12,400

-18,900

-6,968

-66,636

-23,000

28

-153

163

11

46

-16,838

-19,001

2,105

4,001

4,717

-5,693

-23,428

22,095

-14,890

16,068

11,854

-10,759

16,141

6,172

8,251

4,474

764

-62,625

2,426

9,401

-43,094

989

1,040

578

4,007

3,051

Loss from continuing operations

-73,994

-60,055

-59,865

-44,292

-51,635

-54,453

-84,836

-159,416

-7,218

-370,065

-70,996

15,438

-86,354

181,823

-90,343

18,883

-90,617

-67,445

4,373

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) income from discontinued operations, net of tax

0

0

0

1,818

-3,999

256

113,985

-18,844

-22,957

-27,203

-31,674

-138,292

96

619

-2,105

-224,949

-14,515

20,853

661

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-4

-13

-21

-16

-6

-9

53

-28

-59

-53

-17

-9

-112

-47

-60

-33

-82

-1

-1

0

-

0

0

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-73,994

-60,055

-

-

-55,634

-54,197

-

-178,260

-30,175

-397,268

-102,670

-122,854

-86,258

182,442

-92,448

-206,066

-105,132

-46,592

5,034

-5,321

-16,736

-5,157

-4,996

1,198

7,793

18,094

-11,573

20,579

9,265

13,755

7,571

19,582

72,614

11,440

24,241

58,572

21,205

15,426

9,432

-3,197

3,811

(Loss) income from continuing operations

-

-

-

-

-

-

-

-

-

-

-

15,434

-86,367

181,802

-90,359

18,877

-90,626

-67,392

4,345

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

96

619

-2,105

-224,949

-14,515

20,853

661

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-

-

-59,865

-

-

-

29,149

-

-

-

-

-122,858

-86,271

182,421

-92,464

-206,072

-105,141

-46,539

5,006

-5,380

-16,789

-5,174

-5,005

1,086

7,746

18,034

-11,606

20,665

9,264

13,754

7,571

-

72,614

11,440

-

-

-

-

-

-

-

Net loss attributable to The Medicines Company

-73,994

-60,055

-

-

-55,634

-54,197

-

-178,260

-30,175

-397,268

-102,670

-122,854

-86,258

182,442

-92,448

-206,066

-105,132

-46,592

5,034

-5,321

-16,736

-5,157

-4,996

1,198

7,793

18,094

-11,573

20,579

9,265

13,755

7,571

19,582

72,614

11,440

24,241

58,572

21,205

15,426

9,432

-3,197

3,811

Basic loss per common share:
Loss from continuing operations (USD per share)

-0.92

-0.80

-0.80

-0.61

-0.70

-0.74

-1.15

-2.15

-0.10

-5.15

-1.00

0.22

-1.23

2.61

-1.31

0.28

-1.35

-1.02

0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) earnings from discontinued operations (USD per share)

0.00

0.00

0.00

0.03

-0.05

0.00

1.54

-0.25

-0.32

-0.38

-0.44

-1.98

0.00

0.01

-0.03

-3.36

-0.22

0.31

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic loss per share (USD per share)

-0.92

-0.80

-0.80

-0.58

-0.75

-0.74

0.39

-2.40

-0.42

-5.53

-1.44

-1.76

-1.23

2.62

-1.34

-3.08

-1.57

-0.71

0.08

-0.08

-0.26

-0.08

-0.08

0.02

0.13

0.33

-0.21

0.39

0.18

0.25

0.14

0.36

1.36

0.21

0.46

1.11

0.40

0.29

0.18

-0.06

0.07

Diluted loss per common share:
Loss from continuing operations (USD per share)

-0.92

-0.80

-0.80

-0.61

-0.70

-0.74

-1.15

-2.15

-0.10

-5.15

-1.00

0.31

-1.23

2.51

-1.31

0.28

-1.35

-1.02

0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) earnings from discontinued operations (USD per share)

0.00

0.00

0.00

0.03

-0.05

0.00

1.54

-0.25

-0.32

-0.38

-0.44

-1.89

0.00

0.01

-0.03

-3.36

-0.22

0.31

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted loss per share (USD per share)

-0.92

-0.80

-0.80

-0.58

-0.75

-0.74

0.39

-2.40

-0.42

-5.53

-1.44

-1.58

-1.23

2.52

-1.34

-3.08

-1.57

-0.71

0.08

-0.07

-0.26

-0.08

-0.08

0.04

0.12

0.30

-0.21

0.37

0.17

0.25

0.14

0.35

1.34

0.21

0.45

1.10

0.40

0.29

0.18

-0.06

0.07

Weighted average number of common shares outstanding:
Basic (shares)

80,129

74,809

74,463

73,589

73,544

73,349

73,802

74,147

72,286

71,918

71,073

70,521

70,194

69,711

69,210

69,022

67,137

65,903

65,174

64,806

64,534

64,400

64,152

63,553

59,231

55,553

54,047

53,212

52,896

54,035

54,037

53,785

53,534

53,441

53,224

105,505

52,991

52,819

52

52,298

52,232

Diluted (shares)

80,129

74,809

74,463

73,589

73,544

73,349

73,802

74,147

72,286

71,918

71,073

80,175

70,194

72,509

69,210

67,267

67,137

65,903

66,929

73,586

64,534

64,400

64,152

73,127

63,173

60,261

54,047

55,011

55,145

55,556

55,672

54,945

54,260

54,314

54,109

106,400

53,359

52,924

52

52,298

52,532